Subscribe to Newsletter

Advanced Medicine

Manufacture Bioprocessing - Upstream & Downstream

Continuing the Trend

Cell therapy could be the next area to benefit from continuous production processes.

Manufacture Advanced Medicine

Believe in RNAi

| Geert Cauwenbergh

Geert Cauwenbergh believes that RNAi could be the therapeutic of the future.

Manufacture Technology and Equipment

Mini Mimic

| William Aryitey

Could body-on-chip platforms eventually replace current pre-clinical animal models?

Manufacture Advanced Medicine

Automating the Future

| Kim Nelson

To ensure that cell therapy manufacture runs smoothly, the industry must embrace automation.

Manufacture Advanced Medicine

Getting Personal with Oncology

| Joe Olechno

Ex vivo screening techniques could revolutionize cancer treatment.

Manufacture Contract Development Services

Twenty-First Century Cell Therapy

| Denis Bedoret

When making advanced medicines, the cost of manufacture must be lower than reimbursement

Manufacture Standards & Regulation

Making Therapeutic History

| William Aryitey

The FDA approval of Kymriah marks the first CAR-T cell-based gene therapy available in the US

Manufacture Drug Delivery

The Golden Touch

| James Strachan

What does “manufacturing” drugs in the body mean for chemotherapy?

Manufacture Business Practice

Here’s to Shared Successes!

| Stephanie Vine

This issue marks The Medicine Maker's third birthday!

Manufacture Bioprocessing - Upstream & Downstream

Banking on Cell Therapy

| Steve Oh

Sitting down with Steve Oh from the Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register